Ensartinib Desfluoro Impurity - Request Quote
Ensartinib Desfluoro Impurity
| SZ CAT No: | SZ-E141003 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N6O3 |
| Mol.Wt. | 543.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ensartinib Desfluoro Impurity is chemically 6-Amino-5-((R)-1-(2,6-dichlorophenyl)ethoxy)-N-(4-((3R,5S)-3,5-dimethylpiperazine-1-carbonyl)phenyl)pyridazine-3-carboxamide. Ensartinib Desfluoro Impurity is supplied with detailed characterization data compliant with regulatory guideline. Ensartinib Desfluoro Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ensartinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Ensartinib Desfluoro Impurity
Purchase Ensartinib Desfluoro Impurity
Ensartinib Desfluoro Impurity suppliers
Ensartinib Desfluoro Impurity manufacturers
Ensartinib Desfluoro Impurity price
Order Ensartinib Desfluoro Impurity
Enquire Ensartinib Desfluoro Impurity
Ensartinib Desfluoro Impurity cost
Ensartinib Desfluoro Impurity Supplier
Ensartinib Desfluoro Impurity Distributor
Ensartinib Desfluoro Impurity for Method Validation
Ensartinib Reference Standard
Ensartinib Desfluoro Impurity for ANDA Filing
Ensartinib Desfluoro Impurity for Forced Degradation Studies
Ensartinib Desfluoro Impurity Identification Standards
Ensartinib Desfluoro Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.